Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 CAD | 0.00% | 0.00% | -49.55% |
Sales 2024 * | - | Sales 2025 * | 1.04M 760K | Capitalization | 26.56M 19.37M |
---|---|---|---|---|---|
Net income 2024 * | -74M -53.96M | Net income 2025 * | -54M -39.37M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 25.5 x |
P/E ratio 2024 * |
-0.24
x | P/E ratio 2025 * |
-0.35
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.93% |
Latest transcript on Aptose Biosciences Inc.
1 month | -15.92% | ||
3 months | -38.99% | ||
6 months | -60.24% | ||
Current year | -49.55% |
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 1.69 | 0.00% | 4 888 |
24-05-06 | 1.69 | +3.05% | 3,675 |
24-05-03 | 1.64 | -0.61% | 4,133 |
24-05-02 | 1.65 | -0.60% | 3,109 |
24-05-01 | 1.66 | -1.78% | 15,277 |
Delayed Quote Toronto S.E., May 07, 2024 at 12:34 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.55% | 19.45M | |
+20.22% | 46.81B | |
-1.04% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.62% | 26.06B | |
-19.63% | 19.13B | |
+32.25% | 12.39B | |
+0.04% | 12.08B | |
-0.29% | 11.96B |
- Stock Market
- Equities
- APS Stock